Your browser doesn't support javascript.
loading
An In silico Investigation to Identify Promising Inhibitors for SARS-CoV-2 Mpro Target.
Alagarsamy, V; Sundar, P Shyam; Narendhar, B; Sulthana, M T; Kulkarni, Vishaka S; Aishwarya, A Dharshini; Solomon, V Raja; Murugesan, S; Jubie, S; Rohitha, K; Dhanwar, Sangeeta.
Afiliação
  • Alagarsamy V; Medicinal Chemistry Research Laboratory, MNR College of Pharmacy, Sangareddy, 502 294, Gr. Hyderabad, India.
  • Sundar PS; Medicinal Chemistry Research Laboratory, MNR College of Pharmacy, Sangareddy, 502 294, Gr. Hyderabad, India.
  • Narendhar B; Medicinal Chemistry Research Laboratory, MNR College of Pharmacy, Sangareddy, 502 294, Gr. Hyderabad, India.
  • Sulthana MT; Medicinal Chemistry Research Laboratory, MNR College of Pharmacy, Sangareddy, 502 294, Gr. Hyderabad, India.
  • Kulkarni VS; Medicinal Chemistry Research Laboratory, MNR College of Pharmacy, Sangareddy, 502 294, Gr. Hyderabad, India.
  • Aishwarya AD; Medicinal Chemistry Research Laboratory, MNR College of Pharmacy, Sangareddy, 502 294, Gr. Hyderabad, India.
  • Solomon VR; Medicinal Chemistry Research Laboratory, MNR College of Pharmacy, Sangareddy, 502 294, Gr. Hyderabad, India.
  • Murugesan S; Department of Pharmacy, Pilani, Birla Institute of Technology & Sciences Pilani Campus, Pilani-333031, India.
  • Jubie S; Department of Pharmaceutical Chemistry, JSS College of Pharmacy, Udhagamandalam, 643001, India.
  • Rohitha K; Medicinal Chemistry Research Laboratory, MNR College of Pharmacy, Sangareddy, 502 294, Gr. Hyderabad, India.
  • Dhanwar S; Medicinal Chemistry Research Laboratory, MNR College of Pharmacy, Sangareddy, 502 294, Gr. Hyderabad, India.
Med Chem ; 19(9): 925-938, 2023.
Article em En | MEDLINE | ID: mdl-37069723
ABSTRACT

BACKGROUND:

A limited number of small molecules against SARS-CoV-2 has been discovered since the epidemic commenced in November 2019. The conventional medicinal chemistry approach demands more than a decade of the year of laborious research and development and a substantial financial commitment, which is not achievable in the face of the current epidemic.

OBJECTIVE:

This study aims to discover and recognize the most effective and promising small molecules by interacting SARS-CoV-2 Mpro target through computational screening of 39 phytochemicals from five different Ayurvedic medicinal plants.

METHODS:

The phytochemicals were downloaded from Research Collaboratory for Structural Bioinformatics (RCSB) Protein Data Bank (PDB) PubChem, and the SARS-CoV-2 protein (PDB ID 6LU7; Mpro) was taken from the PDB. The molecular interactions, binding energy, and ADMET properties were analyzed.

RESULTS:

The binding affinities were studied using a structure-based drug design of molecular docking, divulging 21 molecules possessing greater to equal affinity towards the target than the reference standard. Molecular docking analysis identified 13 phytochemicals, sennoside-B (-9.5 kcal/mol), isotrilobine (-9.4 kcal/mol), trilobine (-9.0 kcal/mol), serratagenic acid (-8.1 kcal/mol), fistulin (-8.0 kcal/mol), friedelin (-7.9 kcal/mol), oleanolic acid (-7.9 kcal/mol), uncinatone (-7.8 kcal/mol), 3,4-di- O-caffeoylquinic acid (-7.4 kcal/mol), clemaphenol A (-7.3 kcal/mol), pectolinarigenin (-7.2 kcal/mol), leucocyanidin (-7.2 kcal/mol), and 28-acetyl botulin (-7.2 kcal/mol) from ayurvedic medicinal plants phytochemicals possess greater affinity than the reference standard Molnupiravir (-7.0 kcal/mol) against SARS-CoV-2-Mpro.

CONCLUSION:

Two molecules, namely sennoside-B, and isotrilobine with low binding energies, were predicted as most promising. Furthermore, we carried out molecular dynamics simulations for the sennoside-B protein complexes based on the docking score. ADMET properties prediction confirmed that the selected docked phytochemicals were optimal. These compounds can be investigated further and utilized as a parent core molecule to create novel lead molecules for preventing COVID-19.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Idioma: En Revista: Med Chem Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Idioma: En Revista: Med Chem Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Índia